查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492384

卡比馬唑市場：按適應症、最終用戶、分銷管道分類 - 全球預測 2024-2030

Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年卡比馬唑市場規模為2.3491億美元，預計2024年將達2.459億美元，2030年將達3.2659億美元，複合年成長率為4.81%。

卡比馬唑是一種藥物化合物，主要用於治療甲狀腺亢進（甲狀腺激素分泌過多）。卡比馬唑減少這些甲狀腺激素的產生，從而緩解與甲狀腺功能亢進相關的症狀（例如心率加速、出汗過多和不明原因的體重減輕）。全球甲狀腺相關疾病（包括甲狀腺功能亢進）的發生率不斷上升，推動了對卡比馬唑等有效治療方案的需求。此外，人們對甲狀腺健康的認知不斷提高，以及準確、早期檢測甲狀腺疾病的診斷方法不斷進步，也推動了市場的成長。然而，與卡比馬唑相關的副作用和安全性問題，包括粒細胞缺乏症（一種罕見但嚴重的白血球計數減少），可能會限制其使用。然而，對卡比馬唑的遺傳標記和個體反應模式的研究可能會帶來更個人化和有效的治療策略，為市場擴張開闢新的途徑。

主要市場統計
基準年[2023] 2.3491億美元
預測年份 [2024] 2.459 億美元
預測年份 [2030] 32659萬美元
複合年成長率（%） 4.81%

區域洞察

美洲尤其是北美的卡比馬唑市場呈現出均衡的成長軌跡。這主要是由於美國和加拿大等國家醫療基礎設施的改善以及對甲狀腺疾病的認知提高。在南美洲，卡比馬唑的取得情況因國家而異，醫療保健政策和經濟條件影響著獲取情況和消費模式。歐洲是卡比馬唑的重要市場，英國、德國和法國等國甲狀腺疾病盛行率較高，醫療保健系統也強大。市場受益於全面的醫療保險，有助於獲得卡比馬唑等藥物。由於醫療成本上升和人們對甲狀腺疾病的認知不斷提高，亞太地區正在迅速擴張。包括中國和印度在內的人口眾多的國家有大量的人受到甲狀腺疾病的影響，這對這一成長至關重要。政府改善醫療基礎設施和中階富裕程度的努力催生了卡比馬唑。

FPNV定位矩陣

FPNV 定位矩陣對於評估卡比馬唑市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對卡比馬唑市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對卡比馬唑市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 甲狀腺疾病盛行率增加
      • 甲狀腺健康意識和診斷的進展
      • 改善新興經濟體的醫療保健基礎設施和獲得照護的機會
    • 抑制因素
      • 甲狀腺功能亢進症替代治療方案的可用性
    • 機會
      • 研究遺傳標記和個體反應模式
      • 開發更有效且對患者友善的卡比馬唑製劑
    • 任務
      • 卡比馬唑相關的副作用與安全性問題
  • 市場區隔分析
    • 適應症：卡比馬唑在治療格雷夫茲病的重要性，此病會抑制甲狀腺激素的合成
    • 最終使用者：提供卡比馬唑處方箋治療甲狀腺亢進的診所的理想性
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 卡比馬唑市場的適應症

  • 格雷夫茲病
  • 毒性多結節性甲狀腺腫

第7章 卡比馬唑市場：依最終用戶分類

  • 診所
  • 醫院

第8章卡比馬唑市場：依分銷管道

  • 網路藥房
  • 零售藥房

第9章 美洲卡比馬唑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區卡比馬唑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲卡比馬唑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 剪切機-Smith 推出甲硫咪唑片，學名藥
    • Manx Healthcare 推出卡比馬唑錠劑，擴大非專利藥產品組合
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-6B0EA0797583

[182 Pages Report] The Carbimazole Market size was estimated at USD 234.91 million in 2023 and expected to reach USD 245.90 million in 2024, at a CAGR 4.81% to reach USD 326.59 million by 2030.

The carbimazole is a medical compound primarily utilized for treating hyperthyroidism, a condition where the thyroid gland produces excessive thyroid hormones. Carbimazole functions by decreasing the production of these thyroid hormones, thereby alleviating symptoms associated with hyperthyroidism, including rapid heartbeat, excessive sweating, and unexplained weight loss. The rise in the global incidence rate of thyroid-related disorders, including hyperthyroidism, propels the need for effective treatment options such as carbimazole. Moreover, enhanced awareness about thyroid health and advancements in diagnostic approaches for accurate and early detection of thyroid disorders stimulate market growth. However, side effects and safety concerns associated with carbimazole, including agranulocytosis, a rare but serious reduction in white blood cell count, which may limit its usage. Nevertheless, research into genetic markers and individual response patterns to Carbimazole can lead to more personalized and effective treatment strategies, opening new avenues for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 234.91 million
Estimated Year [2024] USD 245.90 million
Forecast Year [2030] USD 326.59 million
CAGR (%) 4.81%

Regional Insights

The carbimazole market in the Americas, particularly in North America, demonstrates a balanced growth trajectory. This is largely due to the well-established healthcare infrastructure and heightened awareness regarding thyroid disorders in countries including the United States and Canada. In South America, access to carbimazole varies by country, with healthcare policies and the economic landscape influencing availability and consumption patterns. Europe represents a significant market for carbimazole, attributed to a higher prevalence of thyroid disorders and robust healthcare systems in countries including the U.K., Germany, and France. The market here benefits from comprehensive healthcare coverage that facilitates access to medications like carbimazole. The Asia Pacific region witnesses a rapid expansion driven by increasing healthcare expenditures and rising awareness of thyroid disorders. Countries including China and India, with their vast populations, are pivotal to this growth, harboring a substantial number of individuals affected by thyroid issues. Government initiatives aimed at improving healthcare infrastructure, along with growing middle-class affluence, are facilitating better access to medications, including carbimazole.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Carbimazole Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of thyroid disorders
      • Enhanced awareness about thyroid health and advancements in diagnostic
      • Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies
    • Market Restraints
      • Availability of alternative treatment options for hyperthyroidism
    • Market Opportunities
      • Research into genetic markers and individual response patterns
      • Development of more efficient and patient-friendly Carbimazole formulations
    • Market Challenges
      • Side effects and safety concerns associated with carbimazole
  • Market Segmentation Analysis
    • Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
    • End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carbimazole Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carbimazole Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders

Upsher-Smith has introduced generic Methimazole Tablets in 5 mg and 10 mg dosages, designed as an alternative to King Pharmaceuticals' Tapazole. These tablets are clinically recommended for individuals diagnosed with Graves' disease exhibiting hyperthyroidism, or those with toxic multinodular goiter, especially when surgical or radioactive iodine treatments are not viable options. Additionally, Methimazole serves to alleviate the symptoms of hyperthyroidism, making it a preparatory treatment before undergoing thyroidectomy or radioactive iodine therapy. [Published On: 2024-02-04]

Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch

Manx Healthcare proudly announces the expansion of its Generics portfolio with the introduction of Carbimazole Tablets in 5mg and 20mg dosages. Available in packs of 100 tablets, these new offerings align with the company's commitment to broadening its product range. [Published On: 2022-05-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carbimazole Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Carbimazole Market, highlighting leading vendors and their innovative profiles. These include DCM Pharma Pvt. Ltd., Devlife Corporatio, Diffzene Pharmaceuticals, HCX Pharmaceuticals LLP, Healthy Inc., Manx Healthcare, Morningside Healthcare Ltd., Naiom Healthcare Private Limited, Newlife Medicare Private Limited, Omicron Pharma Private Limited, Psychocare Health Private Limited, and Steris Healthcare Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Carbimazole Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Graves' Disease
    • Toxic Multinodular Goiter
  • End users
    • Clinics
    • Hospitals
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of thyroid disorders
      • 5.1.1.2. Enhanced awareness about thyroid health and advancements in diagnostic
      • 5.1.1.3. Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment options for hyperthyroidism
    • 5.1.3. Opportunities
      • 5.1.3.1. Research into genetic markers and individual response patterns
      • 5.1.3.2. Development of more efficient and patient-friendly Carbimazole formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and safety concerns associated with carbimazole
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
    • 5.2.2. End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Carbimazole Market, by Indication

  • 6.1. Introduction
  • 6.2. Graves' Disease
  • 6.3. Toxic Multinodular Goiter

7. Carbimazole Market, by End users

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospitals

8. Carbimazole Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online Pharmacies
  • 8.3. Retail Pharmacies

9. Americas Carbimazole Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Carbimazole Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Carbimazole Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders
    • 12.3.2. Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARBIMAZOLE MARKET RESEARCH PROCESS
  • FIGURE 2. CARBIMAZOLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARBIMAZOLE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARBIMAZOLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARBIMAZOLE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023